AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
INTRAVASCULAR ULTRASOUND IMAGING OF ATHEROSCLEROTIC RENAL-ARTERIES - COMPARISON BETWEEN IN-VITRO AND IN-VIVO STUDIES
Authors: YASUDA G TAKIZAWA T TAKASAKI I SHIONOIRI H UMEMURA S SHIMOYAMA K
Citation: G. Yasuda et al., INTRAVASCULAR ULTRASOUND IMAGING OF ATHEROSCLEROTIC RENAL-ARTERIES - COMPARISON BETWEEN IN-VITRO AND IN-VIVO STUDIES, Nephrology, dialysis, transplantation, 13(7), 1998, pp. 1690-1695
EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE AND DIETARY SALT INTAKE ON LEFT-VENTRICULAR HYPERTROPHY IN DAHL SALT-SENSITIVE RATS
Authors: SUGIMOTO K FUJIMURA A TAKASAKI I TOKITA Y IWAMOTO T TAKIZAWA T GOTOH E SHIONOIRI H ISHII M
Citation: K. Sugimoto et al., EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE AND DIETARY SALT INTAKE ON LEFT-VENTRICULAR HYPERTROPHY IN DAHL SALT-SENSITIVE RATS, HYPERTENS R, 21(3), 1998, pp. 163-168
LONG-TERM THERAPY WITH AN ACE-INHIBITOR, TEMOCAPRIL, REDUCES MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION
Authors: SHIONOIRI H SUGIMOTO K KOSAKA T KITA E ODA H USHIKUBO T GOTO T TAKASAKI I YASUDA G
Citation: H. Shionoiri et al., LONG-TERM THERAPY WITH AN ACE-INHIBITOR, TEMOCAPRIL, REDUCES MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION, HYPERTENS R, 21(2), 1998, pp. 81-87
EFFECT OF LONG-TERM THERAPY WITH AN ACE-INHIBITOR AND A DIURETIC ON MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION
Authors: SHIONOIRI H YASUDA G SUGIMOTO K NARUSE M TAKIZAWA T TAKASAKI I
Citation: H. Shionoiri et al., EFFECT OF LONG-TERM THERAPY WITH AN ACE-INHIBITOR AND A DIURETIC ON MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 2506-2506
COUGH-CHALLENGE TRIAL WITH A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IMIDAPRIL
Authors: SHIONOIRI H TAKASAKI I MINAMISAWA K UEDA S KIHARA M SHINDO K HIROTO S SUGIMOTO K HIMENO H NARUSE M NAGAMOCHI I YASUDA G
Citation: H. Shionoiri et al., COUGH-CHALLENGE TRIAL WITH A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IMIDAPRIL, Journal of clinical pharmacology, 38(5), 1998, pp. 442-446
THE EFFECT OF FUROSEMIDE ON THE LOOP OF HENLE BY USING 0.45-PERCENT NACL LOADING
Authors: YASUDA G TAKIZAWA R SHIBATA K TOCHIKUBO O SHIONOIRI H UMEMURA S ISHII M
Citation: G. Yasuda et al., THE EFFECT OF FUROSEMIDE ON THE LOOP OF HENLE BY USING 0.45-PERCENT NACL LOADING, Journal of the American Society of Nephrology, 8, 1997, pp. 516-516
FOSINOPRIL - CLINICAL PHARMACOKINETICS AND CLINICAL POTENTIAL
Authors: SHIONOIRI H NARUSE M MINAMISAWA K UEDA S HIMENO H HIROTO S TAKASAKI I
Citation: H. Shionoiri et al., FOSINOPRIL - CLINICAL PHARMACOKINETICS AND CLINICAL POTENTIAL, Clinical pharmacokinetics, 32(6), 1997, pp. 460-480
EFFECT OF DOXAZOSIN THERAPY ON GLUCOSE-TOLERANCE AND LIPID-METABOLISMIN HYPERTENSIVE PATIENTS WITH IMPAIRED GLUCOSE-TOLERANCE
Authors: SHIONOIRI H ASHINO K YAMANAKA K SHINDO K HIROTO S ARITA T
Citation: H. Shionoiri et al., EFFECT OF DOXAZOSIN THERAPY ON GLUCOSE-TOLERANCE AND LIPID-METABOLISMIN HYPERTENSIVE PATIENTS WITH IMPAIRED GLUCOSE-TOLERANCE, Clinical therapeutics, 19(3), 1997, pp. 527-536
PROGRESSION OF GLOMERULOSCLEROSIS, RENAL HYPERTROPHY, AND AN INCREASED EXPRESSION OF FIBRONECTIN IN THE RENAL-CORTEX ASSOCIATED WITH AGING AND SALT-INDUCED HYPERTENSION IN DAHL SALT-SENSITIVE RATS
Authors: TAKIZAWA T TAKASAKI I SHIONOIRI H ISHII M
Citation: T. Takizawa et al., PROGRESSION OF GLOMERULOSCLEROSIS, RENAL HYPERTROPHY, AND AN INCREASED EXPRESSION OF FIBRONECTIN IN THE RENAL-CORTEX ASSOCIATED WITH AGING AND SALT-INDUCED HYPERTENSION IN DAHL SALT-SENSITIVE RATS, Life sciences, 61(16), 1997, pp. 1553-1558
THE EFFECT OF TEMOCAPRIL ON MICROALBUMINURIA IN HYPERTENSIVE PATIENTSWITH AND WITHOUT GLUCOSE-INTOLERANCE
Authors: SHIONOIRI H ODA H HIROTO S TAKIZAWA T NARUSE M UEDA S TAKASAKI I YASUDA G
Citation: H. Shionoiri et al., THE EFFECT OF TEMOCAPRIL ON MICROALBUMINURIA IN HYPERTENSIVE PATIENTSWITH AND WITHOUT GLUCOSE-INTOLERANCE, Diabetologia, 40, 1997, pp. 1440-1440
AT(1) RECEPTOR ANTAGONIST, TCV-116, DOES NOT PREVENT CARDIAC-HYPERTROPHY IN SALT-LOADED DAHL SALT-SENSITIVE RATS
Authors: SUGIMOTO K GOTOH E TAKASAKI I EBINA T IWAMOTO T TAKIZAWA T SHIONOIRI H ISHII M
Citation: K. Sugimoto et al., AT(1) RECEPTOR ANTAGONIST, TCV-116, DOES NOT PREVENT CARDIAC-HYPERTROPHY IN SALT-LOADED DAHL SALT-SENSITIVE RATS, Clinical and experimental pharmacology and physiology, 23(4), 1996, pp. 282-286
A CASE-REPORT OF ANGIOEDEMA DURING LONG-TERM (66 MONTHS) ANGIOTENSIN-CONVERTING ENZYME-INHIBITION THERAPY WITH ENALAPRIL
Authors: SHIONOIRI H TAKASAKI I HIRAWA N KIHARA M GOTOH E SASAKI T NAKAJIMA H ISHII M
Citation: H. Shionoiri et al., A CASE-REPORT OF ANGIOEDEMA DURING LONG-TERM (66 MONTHS) ANGIOTENSIN-CONVERTING ENZYME-INHIBITION THERAPY WITH ENALAPRIL, Japanese Circulation Journal, 60(3), 1996, pp. 166-170
PHARMACOKINETICS OF SINGLE-DOSE INTRAVENOUS AMIKACIN IN CRITICALLY ILL PATIENTS UNDERGOING SLOW HEMODIALYSIS
Authors: KIHARA M IKEDA Y TAKAGI N FUJITA H SHIBATA K MASUMORI S SHIRATORI K UMEMURA S SHIONOIRI H ISHII M
Citation: M. Kihara et al., PHARMACOKINETICS OF SINGLE-DOSE INTRAVENOUS AMIKACIN IN CRITICALLY ILL PATIENTS UNDERGOING SLOW HEMODIALYSIS, Intensive care medicine, 21(4), 1995, pp. 348-351
WHETHER IMIDAPRIL SELECTIVELY INHIBITS ANGIOTENSIN-II FORMATION RATHER THAN BRADYKININ DEGRADATION
Authors: SHIONOIRI H TAKASAKI I KIHARA M HIROTO S SUGIMOTO K YASUDA G GOTOH E ISHII M
Citation: H. Shionoiri et al., WHETHER IMIDAPRIL SELECTIVELY INHIBITS ANGIOTENSIN-II FORMATION RATHER THAN BRADYKININ DEGRADATION, Hypertension, 25(6), 1995, pp. 1388-1388
GLUCOSE AND LIPID-METABOLISM DURING CHRONIC THERAPY WITH CILAZAPRIL IN HYPERTENSIVES WITH OR WITHOUT IMPAIRED GLUCOSE-METABOLISM
Authors: SHIONOIRI H ITO T OHTOMI S OGIHARA T
Citation: H. Shionoiri et al., GLUCOSE AND LIPID-METABOLISM DURING CHRONIC THERAPY WITH CILAZAPRIL IN HYPERTENSIVES WITH OR WITHOUT IMPAIRED GLUCOSE-METABOLISM, Hypertension, 25(6), 1995, pp. 1388-1388
LONG-TERM DOXAZOSIN THERAPY MAY IMPROVE GLUCOSE AND LIPID-METABOLISM IN HYPERTENSIVES WITH DYSLIPIDEMIA OR DIABETES
Authors: SHIONOIRI H ASHINO K YAMANAKA K HIROTO S ARITA T
Citation: H. Shionoiri et al., LONG-TERM DOXAZOSIN THERAPY MAY IMPROVE GLUCOSE AND LIPID-METABOLISM IN HYPERTENSIVES WITH DYSLIPIDEMIA OR DIABETES, Hypertension, 25(6), 1995, pp. 1404-1404
EFFECT OF CILAZAPRIL THERAPY ON GLUCOSE AND LIPID-METABOLISM IN PATIENTS WITH HYPERTENSION
Authors: SHIONOIRI H TAKASAKI I NARUSE M NAGAMOTI I HIMENO H ITO T OHTOMI S HATA T SHINDO K MIKAMI H OGIHARA T ISHII M
Citation: H. Shionoiri et al., EFFECT OF CILAZAPRIL THERAPY ON GLUCOSE AND LIPID-METABOLISM IN PATIENTS WITH HYPERTENSION, Clinical therapeutics, 17(6), 1995, pp. 1126-1135
PHARMACOKINETICS AND PHARMACODYNAMICS OF NISOLDIPINE IN HYPERTENSIVE PATIENTS WITH NORMAL AND MILD-TO-MODERATE IMPAIRED RENAL-FUNCTION
Authors: SHIONOIRI H MINAMISAWA K MASUMORI S SATTA H MINAMISAWA M TAKIZAWA T JINNO Y TAKEDA K NAGASAWA T TAKASAKI I SUGIMOTO K ISHII M
Citation: H. Shionoiri et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF NISOLDIPINE IN HYPERTENSIVE PATIENTS WITH NORMAL AND MILD-TO-MODERATE IMPAIRED RENAL-FUNCTION, Arzneimittel-Forschung, 45(7), 1995, pp. 785-789
EXAGGERATED BLOOD-PRESSURE RESPONSE TO ANGIOTENSIN-II IN PATIENTS WITH CUSHINGS-SYNDROME DUE TO ADRENOCORTICAL ADENOMA
Authors: YASUDA G SHIONOIRI H UMEMURA S TAKASAKI I ISHII M
Citation: G. Yasuda et al., EXAGGERATED BLOOD-PRESSURE RESPONSE TO ANGIOTENSIN-II IN PATIENTS WITH CUSHINGS-SYNDROME DUE TO ADRENOCORTICAL ADENOMA, European journal of endocrinology, 131(6), 1994, pp. 582-588
EFFECTS OF HYPERTENSION AND AGING ON FIBRONECTIN EXPRESSION IN AORTA OF DAHL SALT-SENSITIVE RATS
Authors: TAKASAKI I TAKIZAWA T SUGIMOTO K GOTOH E SHIONOIRI H ISHII M
Citation: I. Takasaki et al., EFFECTS OF HYPERTENSION AND AGING ON FIBRONECTIN EXPRESSION IN AORTA OF DAHL SALT-SENSITIVE RATS, American journal of physiology. Heart and circulatory physiology, 36(4), 1994, pp. 80001523-80001529
THE IMPAIRED CONTROL OF PLASMA-RENIN ACTIVITY IN HYPERTENSIVE PATIENTS WITH END-STAGE RENAL-DISEASE DUE TO CHRONIC GLOMERULONEPHRITIS
Authors: YASUDA G NAGASAWA T UMEMURA S SHIONOIRI H ISHII M
Citation: G. Yasuda et al., THE IMPAIRED CONTROL OF PLASMA-RENIN ACTIVITY IN HYPERTENSIVE PATIENTS WITH END-STAGE RENAL-DISEASE DUE TO CHRONIC GLOMERULONEPHRITIS, Clinical nephrology, 42(5), 1994, pp. 300-308
PHARMACOKINETIC PROFILES OF INTRAVENOUS IMIPENEM CILASTATIN DURING SLOW HEMODIALYSIS IN CRITICALLY ILL PATIENTS/
Authors: KIHARA M IKEDA Y SHIBATA K MASUMORI S EBIRA H SHIRATORI K UEDA S TAKAGI N UMEMURA S SHIONOIRI H ISHII M
Citation: M. Kihara et al., PHARMACOKINETIC PROFILES OF INTRAVENOUS IMIPENEM CILASTATIN DURING SLOW HEMODIALYSIS IN CRITICALLY ILL PATIENTS/, Clinical nephrology, 42(3), 1994, pp. 193-197
FELODIPINE THERAPY MAY NOT ALTER GLUCOSE AND LIPID-METABOLISM IN HYPERTENSIVES
Authors: SHIONOIRI H TAKIZAWA T OHYAMA Y ISHII J KITAYAMA S NAGASAWA T KITAMOTO K NAGASAWA K HARIYA Y SATO R ITO T ISHII M
Citation: H. Shionoiri et al., FELODIPINE THERAPY MAY NOT ALTER GLUCOSE AND LIPID-METABOLISM IN HYPERTENSIVES, Hypertension, 23(1), 1994, pp. 90000215-90000219
SLOW HEMODIALYSIS PERFORMED DURING THE DAY IN MANAGING RENAL-FAILURE IN CRITICALLY ILL PATIENTS
Authors: KIHARA M IKEDA Y SHIBATA K MASUMORI S FUJITA J EBIRA H TOYA Y TAKAGI N SHIONOIRI H UMEMURA S ISHII M
Citation: M. Kihara et al., SLOW HEMODIALYSIS PERFORMED DURING THE DAY IN MANAGING RENAL-FAILURE IN CRITICALLY ILL PATIENTS, Nephron, 67(1), 1994, pp. 36-41
PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ALPHA(1)-ADRENERGIC ANTAGONIST BUNAZOSIN RETARD IN HYPERTENSIVES
Authors: SHIONOIRI H MINAMISAWA M UEDA S MINAMISAWA K TAKIZAWA T TAKASAKI I SUGIMOTO K GOTOH E ISHII M
Citation: H. Shionoiri et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ALPHA(1)-ADRENERGIC ANTAGONIST BUNAZOSIN RETARD IN HYPERTENSIVES, Arzneimittel-Forschung, 44-2(11), 1994, pp. 1191-1195
Risultati: 1-25 | 26-29